Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Oct 30, 2025

Research supports that iron dysregulation may drive AMD

Author(s): Sydney M Crago Key Takeaways Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry AMD and GA. Transferrin, regulating iron homeostasis, is a potential…

Research supports that iron dysregulation may drive AMD

Oct 24, 2025

Starting from scratch on neovascular age-related macular degeneration

Author(s): Lynda Charters Key Takeaways Gene therapy for nAMD offers potential to reduce treatment burden and improve vision, but long-term safety and efficacy remain concerns. Various gene delivery systems, including…

Starting from scratch on neovascular age-related macular degeneration

Oct 16, 2025

Consumer technology has limitations for assistive needs

By: Roland Mattern Fact checked by: Christine Klimanskis, ELS Key takeaways: Accessibility features in mainstream technology are not as reliable as those in dedicated assistive devices. Purpose-built assistive technology has…

Consumer technology has limitations for assistive needs

Oct 10, 2025

Sharper vision starts here

Sharper vision starts here Author(s)Jack M. Chapman, MD Fact checked by: Sheryl Stevenson Key Takeaways Over 75% of cataract patients have preoperative corneal astigmatism, yet toric IOLs are used in only…

Sharper vision starts here

Oct 10, 2025

Seeing Stars: Gould & Steele interview

Permission was given by Martha Steele & Ellen Gould to share this podcast.

Seeing Stars: Gould & Steele interview

Oct 8, 2025

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Publication|Articles|October 6, 2025 Optometry Times Journal September/October digital edition 2025- Volume 17 –  Issue 05 Author(s)Lynda Charters Fact checked by: Karen S. DeLoss, OD, FAAO Eye care providers are uniquely positioned to…

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Sep 26, 2025

Seeing Through the Fog: Understanding Macular Degeneration

Helping with reading, driving, and daily tasks, caregivers often serve as the ‘eyes’ for their loved ones By: Paul Wynn,AARP In her early 40s, Jan* began noticing subtle but troubling…

Seeing Through the Fog: Understanding Macular Degeneration

Sep 23, 2025

New eyedrop raises hopes for less invasive treatment of serious vision conditions

A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising hopes for less invasive treatment of serious vision conditions. The…

New eyedrop raises hopes for less invasive treatment of serious vision conditions

Sep 23, 2025

Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration

Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration by: Michigan Medicine-University of Michigan Newswise — In the United States, age-related macular degeneration is a leading…

Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration

Sep 16, 2025

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Recruiting- Phase 2 ClinicalTrials.gov IDNCT06635148 SponsorJanssen Research & Development, LLC Information Provided byJanssen Research & Development, LLC Clinical Trial Study Start (Actual)2024-09-19 Primary Completion (Estimated) 2029-08-24 Study Completion (Estimated)2030-06-27 Enrollment (Estimated)311…

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Sep 16, 2025

FDA fast tracks SAR402663 intravitreal gene therapy for wet AMD

By:Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR402663 is a one-time intravitreal gene therapy designed to reduce treatment burden. It is currently being investigated in a phase…

FDA fast tracks SAR402663 intravitreal gene therapy for wet AMD

Sep 12, 2025

Sight Science’s TearCare System earns spot in TFOS DEWS III dry eye report

Author(s): Martin David Harp Key Takeaways TearCare System’s inclusion in TFOS DEWS III report validates its clinical efficacy and role in dry eye management. Data from studies such as SAHARA…

Sight Science’s TearCare System earns spot in TFOS DEWS III dry eye report

Sep 9, 2025

A study of the progression of sensitivity loss in GA over time using inferred data

Author(s): Lynda Charters Key Takeaways Inferred sensitivity mapping predicts retinal function in GA with high spatial resolution, avoiding extensive psychophysical testing. Current GA treatments slow progression but lack functional benefits;…

A study of the progression of sensitivity loss in GA over time using inferred data

Sep 2, 2025

First patient dosed in Qlaris Bio’s phase 2 Nightingale clinical trial for QLS-111

By: Jordana Joy, Associate Editor The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients with normal tension glaucoma. The first patient has been dosed…

First patient dosed in Qlaris Bio’s phase 2 Nightingale clinical trial for QLS-111

Sep 2, 2025

Inside genetics and glaucoma

August 28, 2025 By Kyra Dorgeloh, OD, FAAO Thomas A. Wong, OD, FAAO Glaucoma is a general term for a diverse group of complex disorders characterized by progressive degeneration of the…

Inside genetics and glaucoma

Aug 26, 2025

VG801 receives regenerative medicine advanced therapy designation for Stargardt disease

By: Alex Young Fact checked by : Christine Klimanskis, ELS Key takeaways: VG801 is a dual-AAV gene therapy in development for the treatment of Stargardt disease. The therapy is under investigation…

VG801 receives regenerative medicine advanced therapy designation for Stargardt disease

Aug 15, 2025

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Author(s): Lynda Charters Fact checked by: Karen S. DeLoss, OD, FAAO Key Takeaways Ocular exams can reveal cardiovascular health issues, especially in women, whose symptoms often differ from traditional expectations.…

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Aug 12, 2025

Cosmetic procedures associated with serious ophthalmologic complications

Author(s): Lynda Charters Key Takeaways Minimally invasive cosmetic procedures can cause rare but severe ophthalmological complications, including irreversible vision loss from central retinal artery occlusion. Prevention is crucial due to…

Cosmetic procedures associated with serious ophthalmologic complications

Aug 11, 2025

EyePoint completes enrollment in second phase 3 trial of sustained-release AMD therapy

ByJay S. Duker, MD ByAlex Young ByAnthony DeFino Fact checked by Christine Klimanskis, ELS Key takeaways: More than 400 patients have been enrolled in the LUCIA trial investigating Duravyu. EyePoint…

EyePoint completes enrollment in second phase 3 trial of sustained-release AMD therapy

Aug 11, 2025

This common fruit has over 1,600 compounds that boost brain, heart, and gut health

Published August 6, 2025 | Originally published on ScienceDaily Top Health A new article appearing in the current issue of the peer-reviewed Journal of Agriculture and Food Chemistry explores the concept of “superfoods” and makes…

This common fruit has over 1,600 compounds that boost brain, heart, and gut health

Aug 6, 2025

Study supports Iluvien as ‘long-acting option’ in diabetic macular edema

Key takeaways: The NEW DAY study did not meet its primary endpoint but showed good outcomes in secondary endpoints. A post hoc analysis achieved its primary endpoint. LONG BEACH, Calif.…

Study supports Iluvien as ‘long-acting option’ in diabetic macular edema

Aug 5, 2025

Geographic Atrophy Patient Experience Research

A new study is being conducted on geographic atrophy. They would like to hear about your experience with the drug Izervay. This is a 60-minute phone interview. Please contact Grace,…

Geographic Atrophy Patient Experience Research

Jul 31, 2025

Phase 3 study of LUMIFY Preservative Free and LUMIFY eye drops meets primary end point

Author(s): Jordana Joy Key Takeaways LUMIFY Preservative Free eye drops are statistically non-inferior to LUMIFY in reducing ocular redness, with similar efficacy and safety profiles. The study involved 380 participants,…

Phase 3 study of LUMIFY Preservative Free and LUMIFY eye drops meets primary end point

Jul 28, 2025

VA-developed RainDrop Dispenser Aid aims to simplify use of single-use eye drops for patients with arthritis, tremors July 24, 2025

July 24, 2025 by Lynda Charters, Jordana Joy, Associate Editor Rain Eye Drops LLC announced the launch of a newly refined first-of-its-kind RainDrop Dispenser Aid created specifically for single-use preservative-free…

VA-developed RainDrop Dispenser Aid aims to simplify use of single-use eye drops for patients with arthritis, tremors July 24, 2025

Jul 24, 2025

Novel AI-powered retina tracker detects eye disease in under one second

By: The Endocrine Society A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study being presented Monday at ENDO 2025, the…

Novel AI-powered retina tracker detects eye disease in under one second

Jul 24, 2025

Oral danegaptide for diabetic retinopathy successfully completes phase 1b trial

By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Danegaptide could be an oral therapy for patients with moderate to severe nonproliferative diabetic retinopathy. The treatment was well…

Oral danegaptide for diabetic retinopathy successfully completes phase 1b trial

Jul 24, 2025

Survey finds majority of US patients delaying eye care despite experiencing poor eyesight, eye health

By: Jordana Joy, Associate Editor Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.

Survey finds majority of US patients delaying eye care despite experiencing poor eyesight, eye health

Jul 24, 2025

FDA fast tracks one-time intravitreal gene therapy for geographic atrophy

By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR446597 is designed to inhibit C1s and factor Bb in the complement pathway. Fast-track designation expedites the development and…

FDA fast tracks one-time intravitreal gene therapy for geographic atrophy

Jul 8, 2025

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD

Author(s): Martin David Harp Key Takeaways Alcon’s acquisition of LumiThera includes a PBM device for early and intermediate dry AMD, enhancing its non-invasive treatment portfolio. LumiThera’s PBM device demonstrated significant…

Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD

Jul 8, 2025

Can you eye doctor predict an impending stroke?

A university study shows certain types of retina problems are early signs of stroke. Research scientists from the University of Sydney in Australia screened the eyes of 3,654 healthy adults…

Can you eye doctor predict an impending stroke?

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.